ochna/flavonoid

Two biflavonoids namely, 2",3"-dihydroochnaflavone and 2",3"-dihydroochnaflavone 7"-O-methyl ether, and a flavonoid glycoside, 6-gamma,gamma-dimethylallyltaxifolin 7-O-beta-D-glucoside were isolated from the leaves of Ochna integerrima.

Fractionation of the methanolic extract of Ochna afzelii stem bark has resulted in the isolation of two biflavonoids afzelones A and B along with five known flavonoids, calodenins A and B, afzelone C, 4',5-dimethoxy-6,7-methylenedioxyisoflavone, 4',5,7-trimethoxyisoflavone and the glucoside

Bioassay-guided fractionation of the anti-HIV-1 active EtOAc extract from leaves and twigs of Ochna integerrima led to the isolation of five new flavonoid glycosides 1 - 5, five known flavonoids 6 - 10, and two known flavonoid glycosides 11 and 12. Structures were determined based on spectroscopic

The genus Ochna L. (Gr, Ochne; wild pear), belonging to the Ochnaceae family, includes ca. 85 species of evergreen trees, shrubs, and shrublets, distributed in tropical Asia, Africa, and America. Several members of this genus have long been used in folk medicine for treatment of various ailments,

7-O-Methyltetrahydroochnaflavone (1), a new biflavanone, together with nine known flavonoids, afrormosin (2), 2,3-dihydroochnaflavone 7-O-methyl ether (3), kaempferol (4), 2,3-dihydroochnaflavone (5), ochnaflavone (6), (-)-epicatechin (7), kaempferol 3-O-rhamnoside (8), taxifolin 3-O-rhamnoside (9),

Seven flavonoids, hemerocallone (1), 6,7-dimethoxy-3',4'-dimethoxyisoflavone (2), amentoflavone (4), agathisflavone (6), cupressuflavone (8), robustaflavone (9) and epicatechin (10), together with three other compounds, lithospermoside (3), β-D-fructofuranosyl-α-D-glucopyranoside (5) and

Ochna schweinfurthiana has been used in traditional medicine to treat pain, inflammation, and arthritis. It is a rich source of complex dimers of flavonoids with potential use as templates for the development of therapeutic drugs. Hence, the aim of this study was to study the phytochemical

Cooccurrence of Diabetes Mellitus and Alzheimer's disease in elder people prompts scientists to develop multitarget agents that combat causes and symptoms of both diseases simultaneously. In line with this modern paradigm and as a follow-up to our previous studies, the present study is designed to